AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32533295 — intervention group
Group type: COMPARATOR
Intervention: Standard, clinic-based Parent-Child Interaction Therapy (PCIT)
Number of subjects: 40
Study 616222542 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor 60 mg bid
Number of subjects: 180
Study 616222542 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor 90 mg bid
Number of subjects: 180
Study 616222542 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 180
Study 35904308 — intervention group
Group type: EXPERIMENTAL
Intervention: Telehealth supervised home core stabilization program for 8 weeks
Number of subjects: 54
Study 35904308 — intervention group
Group type: COMPARATOR
Intervention: No exercise (Control group)
Number of subjects: 54
Study 33461559 — intervention group
Group type: EXPERIMENTAL
Intervention: SPOTLIGHT Virtual Audit Tool (S‐VAT)
Number of subjects: 148
Study 32278637 — intervention group
Group type: EXPERIMENTAL
Intervention: RFA with compression stocking for two weeks
Number of subjects: 100
Study 32278637 — intervention group
Group type: COMPARATOR
Intervention: RFA alone
Number of subjects: 100
Study 34525968 — intervention group
Group type: EXPERIMENTAL
Intervention: Cabozantinib
Number of subjects: 0
Study 34525968 — intervention group
Group type: COMPARATOR
Intervention: Everolimus
Number of subjects: 0
Study 36274681 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixture of autologous adipose-derived stem cells (ASCs) and platelet rich plasma (PRP)
Number of subjects: 15
Study 36274681 — intervention group
Group type: COMPARATOR
Intervention: Enamel matrix derivative administration
Number of subjects: 15
Study 32947142 — intervention group
Group type: EXPERIMENTAL
Intervention: Uterine-preserving surgery
Number of subjects: 77
Study 32947142 — intervention group
Group type: COMPARATOR
Intervention: Non-uterine-preserving surgery
Number of subjects: 77
Study 35672455 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute exercise
Number of subjects: 26
Study 35672455 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise training (12-week program)
Number of subjects: 26
Study 34916634 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimal split-thickness envelope flap (test group)
Number of subjects: 28
Study 34916634 — intervention group
Group type: COMPARATOR
Intervention: Flap with no vertical releasing incision (control group)
Number of subjects: 28
Study 34916634 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (test and control)
Number of subjects: 28
Study 34910230 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term preoperative drainage (< 4 weeks)
Number of subjects: 170
Study 34910230 — intervention group
Group type: COMPARATOR
Intervention: Long-term preoperative drainage (≥ 4 weeks)
Number of subjects: 170
Study 34910230 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall and recurrence-free survival rates
Number of subjects: 170
Study 32737420 — intervention group
Group type: EXPERIMENTAL
Intervention: GnRH agonist
Number of subjects: 80
Study 32737420 — intervention group
Group type: COMPARATOR
Intervention: GnRH antagonist
Number of subjects: 80
Study 34982826 — intervention group
Group type: EXPERIMENTAL
Intervention: Explicit pain management instructions (Group B)
Number of subjects: 110
Study 34982826 — intervention group
Group type: COMPARATOR
Intervention: General pain management instructions (Group A)
Number of subjects: 110
Study 32969531 — intervention group
Group type: EXPERIMENTAL
Intervention: N95 respirator
Number of subjects: 16
Study 32969531 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical mask
Number of subjects: 16
Study 32969531 — intervention group
Group type: COMPARATOR
Intervention: No mask
Number of subjects: 16
Study 36286657 — intervention group
Group type: EXPERIMENTAL
Intervention: Acveris
Number of subjects: 28
Study 36286657 — intervention group
Group type: COMPARATOR
Intervention: Soliris
Number of subjects: 28
Study 34959861 — intervention group
Group type: EXPERIMENTAL
Intervention: Menthol (MEN)
Number of subjects: 8
Study 34959861 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate (CHO)
Number of subjects: 8
Study 34959861 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination (BOTH)
Number of subjects: 8
Study 35836365 — intervention group
Group type: EXPERIMENTAL
Intervention: Capsaicin
Number of subjects: 46
Study 35836365 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study 33904820 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based intervention
Number of subjects: 451
Study 33904820 — intervention group
Group type: EXPERIMENTAL
Intervention: In-person workshop
Number of subjects: 451
Study 33904820 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 451
Study 36463704 — intervention group
Group type: EXPERIMENTAL
Intervention: Relaxation video
Number of subjects: 142
Study 36463704 — intervention group
Group type: EXPERIMENTAL
Intervention: Information video
Number of subjects: 142
Study 36463704 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 142
Study 36463704 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 142
Study 33545934 — intervention group
Group type: EXPERIMENTAL
Intervention: Bacillus coagulans LBSC, 6 billion/d for 80 days
Number of subjects: 40
Study 33545934 — intervention group
Group type: COMPARATOR
Intervention: Placebo (vehicle)
Number of subjects: 40
Study 33545934 — intervention group
Group type: EXPERIMENTAL
Intervention: Bacillus coagulans LBSC
Number of subjects: 40
Study 34315232 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical decision support system
Number of subjects: 1145
Study 34315232 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 1145
Study 35732969 — intervention group
Group type: EXPERIMENTAL
Intervention: Juvenile Drug Treatment Courts (JDTC)
Number of subjects: 10
Study 35732969 — intervention group
Group type: COMPARATOR
Intervention: Traditional Juvenile Court (TJC)
Number of subjects: 10
Study 35164524 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium plus antipsychotics (Li+AP) (N = 50, primarily quetiapine and aripiprazole)
Number of subjects: 379
Study 35164524 — intervention group
Group type: COMPARATOR
Intervention: Lithium only (control group) (N = 149)
Number of subjects: 379
Study 35164524 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium plus anticonvulsants (Li+AC) (N = 107, primarily lamotrigine and valproate)
Number of subjects: 379
Study 35164524 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium plus antipsychotics and anticonvulsants (Li+AP+AC) (N = 73)
Number of subjects: 379
Study 35164524 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium plus antipsychotics (Li+AP)
Number of subjects: 379
Study 34449859 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel ultrasound device
Number of subjects: 40
Study 34449859 — intervention group
Group type: COMPARATOR
Intervention: Conventional ultrasound device
Number of subjects: 40
Study 32430189 — intervention group
Group type: EXPERIMENTAL
Intervention: YouGrabber (YG) virtual reality training system
Number of subjects: 5
Study 35604687 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupoint hot compress (3 sessions of 4 hours each within 30 minutes, 24 hours, and 48 hours after delivery)
Number of subjects: 1200
Study 35604687 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupoint hot compress
Number of subjects: 1200
Study 33040675 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacist-led interventions
Number of subjects: 65
Study 35242728 — intervention group
Group type: EXPERIMENTAL
Intervention: WhatsApp-based intervention for continued learning
Number of subjects: 208
Study 35242728 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 208
Study 32044039 — intervention group
Group type: EXPERIMENTAL
Intervention: Motor Learning (ML) Group
Number of subjects: 0
Study 32044039 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional Electrical Stimulation (FES) Group
Number of subjects: 0
Study 32044039 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotics Group
Number of subjects: 0
Study 32044039 — intervention group
Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 0
Study 35383052 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV/TB syndemic impact on attitudes towards TB screening
Number of subjects: 820
Study 35383052 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV/TB syndemic impact on attitudes towards TB treatment
Number of subjects: 820
Study 34481111 — intervention group
Group type: EXPERIMENTAL
Intervention: PROERD intervention (ten classes taught by trained police officers)
Number of subjects: 4030
Study 34481111 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 4030
Study 32290852 — intervention group
Group type: EXPERIMENTAL
Intervention: 1000 mg/day synbiotic (Familact) for 12 weeks
Number of subjects: 72
Study 32290852 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 12 weeks
Number of subjects: 72
Study 33634375 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief in-home intervention targeting parenting skills
Number of subjects: 58
Study 33634375 — intervention group
Group type: COMPARATOR
Intervention: Standard pediatric primary care
Number of subjects: 58
Study 33634375 — intervention group
Group type: EXPERIMENTAL
Intervention: Behaviorally-based parenting skills
Number of subjects: 58
Study 33510315 — intervention group
Group type: EXPERIMENTAL
Intervention: Labyrinth‐VR (12 hours of computer game play over four weeks)
Number of subjects: 48
Study 33510315 — intervention group
Group type: COMPARATOR
Intervention: Placebo control game (12 hours of computer game play over four weeks)
Number of subjects: 48
Study 32641374 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Glucose Monitoring (CGM)
Number of subjects: 161
Study 32641374 — intervention group
Group type: COMPARATOR
Intervention: Self-Monitoring of Blood Glucose (SMBG)
Number of subjects: 161
Study 35422467 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine
Number of subjects: 0
Study 35422467 — intervention group
Group type: COMPARATOR
Intervention: Lamotrigine (pre-treatment)
Number of subjects: 0
Study 33640422 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic cranial irradiation (PCI) (25 Gy in 10 fractions)
Number of subjects: 84
Study 33640422 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (SoC)
Number of subjects: 84
Study 33640422 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic cranial irradiation (PCI)
Number of subjects: 84
Study 36364756 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus paracasei IJH-SONE68 fermented pineapple juice
Number of subjects: 80
Study 36364756 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 32555927 — intervention group
Group type: EXPERIMENTAL
Intervention: Levosimendan (12 µg/kg bolus)
Number of subjects: 49
Study 32555927 — intervention group
Group type: EXPERIMENTAL
Intervention: Levosimendan
Number of subjects: 49
Study 32555927 — intervention group
Group type: COMPARATOR
Intervention: Control (routine treatment only)
Number of subjects: 49
Study 32555927 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 49
Study 32555927 — intervention group
Group type: EXPERIMENTAL
Intervention: Levosimendan and Control
Number of subjects: 49
Study 36353052 — intervention group
Group type: EXPERIMENTAL
Intervention: TACmono
Number of subjects: 121
Study 36353052 — intervention group
Group type: COMPARATOR
Intervention: TAC/MMF
Number of subjects: 121
Study 33781980 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-temperature electrocautery
Number of subjects: 5641
Study 33781980 — intervention group
Group type: COMPARATOR
Intervention: Standard electrocautery
Number of subjects: 5641
Study 34265389 — intervention group
Group type: EXPERIMENTAL
Intervention: NoCL (patients without unstable chondral lesions)
Number of subjects: 118
Study 34265389 — intervention group
Group type: COMPARATOR
Intervention: CL-noDeb (patients with unstable chondral lesions)
Number of subjects: 118
Study 34965784 — intervention group
Group type: EXPERIMENTAL
Intervention: Resourcefulness intervention (teaching on social and personal resourcefulness skills, access to intervention video, skill application video-vignettes, four weeks of skills reinforcement using daily logs, four weekly phone contacts, booster sessions at two- and four-month postenrollment)
Number of subjects: 93
Study 34965784 — intervention group
Group type: COMPARATOR
Intervention: Attention control (phone contact at identical time points plus the current standard of care)
Number of subjects: 93
Study 33247707 — intervention group
Group type: EXPERIMENTAL
Intervention: Arglabin
Number of subjects: 0
Study 33247707 — intervention group
Group type: COMPARATOR
Intervention: AC regimen
Number of subjects: 0
Study 33247707 — intervention group
Group type: EXPERIMENTAL
Intervention: AC + Arglabin
Number of subjects: 0
Study 35011093 — intervention group
Group type: EXPERIMENTAL
Intervention: Lemon verbena (Lippia citriodora) extract
Number of subjects: 0
Study 35011093 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32769645 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical repair of pelvic organ prolapse (including transvaginal native tissue repairs, transvaginal mesh or graft-augmented repairs, abdominal sacrocolpopexy)
Number of subjects: 932
Study 32769645 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline dyspareunia
Number of subjects: 932
Study 36126369 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed cord clamping (DCC)
Number of subjects: 198
Study 36126369 — intervention group
Group type: COMPARATOR
Intervention: Early cord clamping (ECC)
Number of subjects: 198
Study 33804123 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-surgical periodontal treatment
Number of subjects: 187
Study 33804123 — intervention group
Group type: COMPARATOR
Intervention: Delayed treatment (Control)
Number of subjects: 187
Study 33597157 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrothermal duodenal mucosal resurfacing (DMR)
Number of subjects: 108
Study 33597157 — intervention group
Group type: COMPARATOR
Intervention: Sham procedure
Number of subjects: 108
Study 33734306 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal aflibercept injection (2 mg) quarterly for 24 months
Number of subjects: 127
Study 33734306 — intervention group
Group type: COMPARATOR
Intervention: Sham injection quarterly for 24 months
Number of subjects: 127
Study 32501541 — intervention group
Group type: EXPERIMENTAL
Intervention: IM doravirine 200 mg (Treatment A: 1×1 mL, 20% suspension)
Number of subjects: 36
Study 32501541 — intervention group
Group type: EXPERIMENTAL
Intervention: IM doravirine 300 mg (Treatment B: 1×0.66 mL, 30% suspension)
Number of subjects: 36
Study 32501541 — intervention group
Group type: EXPERIMENTAL
Intervention: IM doravirine 200 mg (Treatment C: 2×0.5 mL, 20% suspension)
Number of subjects: 36
Study 32501541 — intervention group
Group type: COMPARATOR
Intervention: Oral doravirine
Number of subjects: 36
Study 32501541 — intervention group
Group type: EXPERIMENTAL
Intervention: IM doravirine
Number of subjects: 36
Study 35501626 — intervention group
Group type: EXPERIMENTAL
Intervention: Desktop Virtual Reality (VR)
Number of subjects: 120
Study 35501626 — intervention group
Group type: COMPARATOR
Intervention: Face-to-Face Simulation with Simulated Patient (SP)
Number of subjects: 120
Study 33270531 — intervention group
Group type: EXPERIMENTAL
Intervention: APEX system
Number of subjects: 15
Study 36458387 — intervention group
Group type: EXPERIMENTAL
Intervention: Core stability training (five-week program, three days/week)
Number of subjects: 70
Study 36458387 — intervention group
Group type: COMPARATOR
Intervention: Regular training (control group)
Number of subjects: 70
Study 32869659 — intervention group
Group type: EXPERIMENTAL
Intervention: Food insecurity
Number of subjects: 630
Study 35627562 — intervention group
Group type: EXPERIMENTAL
Intervention: Marine therapy group (MTG)
Number of subjects: 24
Study 35627562 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 24
Study 616759071 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of beta‐TCP and rhGDF‐5 (400 mug)
Number of subjects: 12
Study 616759071 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of beta‐TCP and rhGDF‐5 (800 mug)
Number of subjects: 12
Study 616759071 — intervention group
Group type: COMPARATOR
Intervention: Control group (beta‐TCP only)
Number of subjects: 12
Study 35321886 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium lactate infusion
Number of subjects: 9
Study 35321886 — intervention group
Group type: COMPARATOR
Intervention: Sodium chloride infusion (placebo)
Number of subjects: 9
Study 34903696 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-month lifestyle intervention
Number of subjects: 143
Study 34903696 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 143
Study 35660485 — intervention group
Group type: EXPERIMENTAL
Intervention: Algorithm-based FiO2 titration with electronic medical record-based automated alerts
Number of subjects: 316
Study 35660485 — intervention group
Group type: COMPARATOR
Intervention: Standard practice FiO2 titration
Number of subjects: 316
Study 33388697 — intervention group
Group type: EXPERIMENTAL
Intervention: WM training
Number of subjects: 25
Study 33388697 — intervention group
Group type: COMPARATOR
Intervention: Routine speech therapy (Control)
Number of subjects: 25
Study 34549809 — intervention group
Group type: COMPARATOR
Intervention: sorafenib
Number of subjects: 987
Study 34549809 — intervention group
Group type: COMPARATOR
Intervention: melphalan, prednisone, and thalidomide
Number of subjects: 987
Study 33148299 — intervention group
Group type: EXPERIMENTAL
Intervention: Fire needle acupuncture
Number of subjects: 100
Study 33148299 — intervention group
Group type: COMPARATOR
Intervention: Filiform needle acupuncture
Number of subjects: 100
Study 33507315 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound guided quadratus lumborum block (QLB) using 0.5 mL/kg body weight 0.25% bupivacaine preoperatively
Number of subjects: 40
Study 33507315 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard postoperative analgesia protocol)
Number of subjects: 40
Study 32506135 — intervention group
Group type: EXPERIMENTAL
Intervention: Potassium supplementation (3 g/d)
Number of subjects: 36
Study 32506135 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium supplementation (3 g/d)
Number of subjects: 36
Study 32506135 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 35611615 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week combined aerobic-and neurocognitive-exercise (3 sessions per week for 60-min)
Number of subjects: 80
Study 35611615 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 80
Study 35611615 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined aerobic and neurocognitive exercise intervention
Number of subjects: 80
Study 35611615 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity levels
Number of subjects: 80
Study 33586539 — intervention group
Group type: EXPERIMENTAL
Intervention: COVID-19 perception
Number of subjects: 376
Study 32275191 — intervention group
Group type: EXPERIMENTAL
Intervention: Anakinra (Kineret) for 2 days
Number of subjects: 140
Study 32275191 — intervention group
Group type: EXPERIMENTAL
Intervention: Anakinra (Kineret) for 4 weeks
Number of subjects: 140
Study 32275191 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 140
Study 35073229 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental vignette methodology (four vignettes about alcohol misuse)
Number of subjects: 251
Study 33858430 — intervention group
Group type: EXPERIMENTAL
Intervention: BPH group
Number of subjects: 107
Study 32053816 — intervention group
Group type: EXPERIMENTAL
Intervention: Contrast-enhanced ultrasound (CEUS) performed 48 hours after treatment
Number of subjects: 94
Study 32053816 — intervention group
Group type: COMPARATOR
Intervention: CECT at 1-month (reference standard)
Number of subjects: 94
Study 32053816 — intervention group
Group type: EXPERIMENTAL
Intervention: CEUS responders (48 h after treatment)
Number of subjects: 94
Study 35896969 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous iron therapy
Number of subjects: 75
Study 35896969 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study 35896969 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise training programme (for both groups)
Number of subjects: 75
Study 35896969 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous iron therapy and exercise training
Number of subjects: 75
Study 35896969 — intervention group
Group type: COMPARATOR
Intervention: Placebo and exercise training
Number of subjects: 75
Study 36201834 — intervention group
Group type: EXPERIMENTAL
Intervention: Friend Present condition
Number of subjects: 100
Study 36201834 — intervention group
Group type: COMPARATOR
Intervention: Friend Absent condition
Number of subjects: 100
Study 33763652 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus reuteri supplementation
Number of subjects: 132
Study 33763652 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 132
Study 32101262 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive blood pressure control (target <120 mm Hg)
Number of subjects: 9361
Study 32101262 — intervention group
Group type: COMPARATOR
Intervention: Standard blood pressure control (target <140 mm Hg)
Number of subjects: 9361
Study 34275501 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily oral vitamin D3 drops (3‐12 months: 2000 IU; >12 months‐5y: 4000 IU; n=33) for 12 weeks
Number of subjects: 66
Study 34275501 — intervention group
Group type: COMPARATOR
Intervention: Single oral depot dose of vitamin D3 granules (3‐12 months: 60,000 IU; >12 months‐5y: 150,000 IU; n=33) for 12 weeks
Number of subjects: 66
Study 32650076 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic Isotonic Manipulation Examination (DIME) testing
Number of subjects: 171
Study 32650076 — intervention group
Group type: EXPERIMENTAL
Intervention: DIME strength ≤86.0 N
Number of subjects: 171
Study 32650076 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain at ≤90° on unopposed active abduction in the coronal plane
Number of subjects: 171
Study 35007624 — intervention group
Group type: EXPERIMENTAL
Intervention: Mepolizumab 100 mg subcutaneous every 4 weeks
Number of subjects: 407
Study 35007624 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus standard of care
Number of subjects: 407
Study 36099670 — intervention group
Group type: EXPERIMENTAL
Intervention: docetaxel plus AAP
Number of subjects: 148